Prognostic Significance of Proteomics-Discovered Circulating Inflammatory Biomarkers in Patients With Pulmonary Arterial Hypertension.
Tetsuro YokokawaOlivier BoucheratSandra MartineauSarah-Eve LemaySandra Breuils-BonnetVinod KrishnaShanker Kalyana-SundaramJey JeyaseelanFrançois PotusSebastien BonnetSteeve ProvencherPublished in: Journal of the American Heart Association (2024)
In addition to revealing new actors likely involved in cardiopulmonary remodeling in PAH, our screening identified promising circulating biomarkers to improve risk prediction in PAH, which should be externally confirmed.